Discover
DOCS
Doximity, Inc.
21.59
700 x undefined
900 x undefined
bid
ask
+
0.85
4.10%
800 @ 05:20 AM
21.57 -0.02 (0.09%)
| Ytd | -51.24% | |
| 1y | -63.02% |
20.98
day range
22.26
17.15
52 week range
76.51
| Open | 21.30 | Prev Close | 20.74 | Low | 20.98 | High | 22.26 | Mkt Cap | 3.95B |
| Vol | 2.91M | Avg Vol | 4.12M | EPS | 0.98 | P/E | 22.03 | Forward P/E | 12.98 |
| Beta | 1.29 | Short Ratio | 4.45 | Inst. Own | 99.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 21.90 | 200-d Avg | 38.84 | 1yr Est | 24.37 |
DOCS News
seekingalpha.com
Doximity: Everyone Is Focused On The Guidance While Missing The Valuation And AI Stories
Doximity issued conservative FY2027 guidance, projecting 4% revenue growth and a 49% adjusted EBITDA
benzinga.com
Doximity's AI Expansion Raises Execution Risks: Analyst
Bank of America Securities (BofA) on Monday downgraded Doximity Inc. (NYSE:DOCS), citing limited cla
benzinga.com
Doximity's AI Expansion Raises Execution Risks: Analyst
BofA downgrades Doximity (DOCS) to Underperform, slashing the price target to $20 amid soft pharma a
benzinga.com
This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Top Wall Street analysts changed outlook on top stocks. See all changes including upgrades, downgrad
benzinga.com
B of A Securities Downgrades Doximity to Underperform, Lowers Price Target to $20
B of A Securities analyst Allen Lutz downgrades Doximity (NYSE:DOCS) from Buy to Underperform and
zacks.com
Doximity (DOCS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Doximity (DOCS) concluded the recent trading session at $19.85, signifying a -4.7% move from its pri
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DO
NEW YORK, June 25, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors